Council Member of HNODIS (Jul 14 - Jul 16)
Council Member of HNODS (Sep 08-Sep 13)
Professor of Oncology, Lund University Hospital, Sweden
Current Research Interests
Katarina Svanberg started her research career by studying laser light interaction with biological tissue. Her PhD thesis in Medical Science presented pre-clinical research work within experimental photodynamic therapy and tissue spectroscopy. The post doc research activity has been focussed on clinical application of the pre clinical achievements. K.S. has been active as an invited speaker in more than 100 international scientific conferences. She has 65 peer-reviewed scientific papers and is the co-author of 20 scientific review papers. Katarina Svanberg has combined her clinical activity with research work and thus been able to introduce a new cancer treatment modality in Oncology (Photodynamic Therapy) at the Lund University Hospital. The validation of the new modality was presented after performing two different randomized clinical studies at the hospital. She has been a key person in the collaboration in between several clinics and departments at the Lund University Hospital in introducing and applying laser-induced fluorescence spectroscopy for early tumour detection. K.S. has been instrumental in bringing out this clinical research work to several other countries within scientific networks, including many countries in Europe, Africa and the US. K.S. is a board member of Lund Laser Centre since 1993. Since 1991 she is also a board member of Lund University Medical Laser Centre, where she now serves as the director. K.S. has also been listed as a principal investigator in a research programme within National Institute of Health, Rockville. She is also deputy Lund co-ordinator within an EU-project for laser application in medicine, in which programme industrial as well as scientific partners collaborate and from 2008 the medical coordinator for another EU-project within photonics application for human health. During the years 2004 - 2006 she was appointed as one of the Directors in the Board for the International Society of Optical Engineering, USA. She is now running for president for the society, which has over twenty thousand members.
Katarina Svanberg is co-author of about ten patent applications resulting in a number of granted patents. She is a co-founder and main medical advisor for Spectraphos AB (bought by Xillix Inc), SpectraCure AB, Ideon Research Park, Lund and GasPorox AB, ideon Research Park, Lund. She is since many years a main medical advisor for the US based STI Inc., resulting in US Lund research grants. She is a co-receipient of the SKAPA Innovation Prize in 2004. She received the Innovator award, Society for Industrial Development, Sweden, 2007.
Other relevant qualifications: Royal Scientific Society Interdisciplinary Research Prize, Uppsala 1995, SKAPA Innovation Prize 2004 and the Innovator award, Society for Industrial Development, Sweden, 2007.